Key result
Synthetic CNP-22 and platypus venom-derived peptides form cation-selective channels with ~546 pS conductance.
Why the study?
The mechanism by which synthetic human C-type natriuretic peptide-22 and OaC-type natriuretic peptide-39(18-39) affect membrane compartmentation and related pathologies was not established.
Synthetic C-type natriuretic peptides can form large, weakly cation-selective voltage-gated channels in lipid bilayers, potentially explaining membrane compartmentation loss in CNP-related pathologies.
Does not alter clinical practice; leaves open whether CNP channels contribute to human membrane pathology in vivo.
We report the first evidence that synthetic human C-type natriuretic peptide-22 and the OaC-type natriuretic peptide-39(18-39), a 22 amino acid fragment of the OaC-type natriuretic peptide-39 from platypus venom, can function directly by forming a novel voltage-gated weakly cation-selective channel in negatively charged artificial lipid bilayer membranes. The channel activity is characterized by a tendency for inactivation at negative voltages, e.g. -60 and -70 mV, whereas at positive voltages the channel is fully open. The channel has a maximal cord conductance of 546+/-23 pS (n = 16) and shows weak outward rectification. The sequence and the permeability ratios were P(K)+: P(Cs)+: P(Na)+: P(choline)+ 1:0.88:0.76:0.13, respectively. The addition of 50 mM TEA+ cis (a blocker of outwardly rectifying K+ channels), 20 mM Cs+ cis (a blocker of inwardly rectifying K+ channels) or 0.5 mM glibenclamide cis (a blocker of ATP-sensitive K+ channels) to the cis chamber did not affect the conductance or the kinetics of the OaC-type natriuretic peptide-39(18-39)-formed channels (n = 2-5). It is concluded that the weak cation selectivity, large conductance and high open probability as well as their voltage dependency are consistent with the ability of these peptides to cause that loss of compartmentation of the membrane, which is a characteristic feature of adverse conditions that cause C-type natriuretic peptide-related pathologies.
No takes yet. Share an insight, caveat, or question.
Joseph I. Kourie (1999) studied this question. Synthetic human C-type natriuretic peptide-22 and OaC-type natriuretic peptide-39(18-39) was evaluated on Channel formation and properties (maximal cord conductance, permeability). Synthetic human C-type natriuretic peptide-22 and OaC-type natriuretic peptide-39(18-39) form voltage-gated weakly cation-selective channels with a maximal cord conductance of 546+/-23 pS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: